Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5645 results
Almac Group Leads Economic Growth in Pennsylvania and the U.S.
Almac Group, the global contract development and manufacturing organisation, receives the spotlight for its long-term commitment to expanding its footprint in the greater Philadelphia region.
Drug Research > Drug Discovery & Development > Press Releases
Almac Discovery Announce ALM201 Poster Presentation at 2017 European Society for Medical Oncology Congress
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, will present highlights of the safety data from the ALM201 Phase I trial at the ESMO congress in Madrid, Spain on September 8 – 12 2017.
Drug Research > Drug Discovery & Development > Press Releases
MilliporeSigma opens China's first end-to-end biodevelopment center in Shanghai
MilliporeSigma announced the opening of its first BioReliance end-to-end biodevelopment center in the Asia Pacific (APAC) region.
Drug Research > Drug Discovery & Development > News
GSK, AstraZeneca, Labcyte form alliance to develop acoustic mass spectrometry
Labcyte announced that GSK has joined its consortium with AstraZeneca to combine acoustic liquid dispensing technology from Labcyte with Mass Spectrometry (MS) for use in high throughput small molecule screening and other drug discovery applications.
Drug Research > Drug Discovery & Development > News
Ultragenyx proposes to acquire Dimension Therapeutics
By PBR Staff Writer
Ultragenyx Pharmaceutical has made a proposal to acquire all of the outstanding shares of common stock of Dimension Therapeutics for $5.50 per share, or approximately $138m, in cash at close to be effectuated via a tender offer.
Drug Research > Drug Discovery & Development > News
LTS Broschüre - Deutsche Version
| By Lohmann Therapy System
Am Anfang jedes Erfolgs steht eine Vision. Eine Idee, die etwas verändern soll. Ein Ziel, das man niemals aus den Augen verliert.
Drug Research > Drug Discovery & Development > White Papers
LTS Brochure - English Version
| By Lohmann Therapy System
Success starts with a vision. An idea that will make a difference. A goal you never lose sight of. At LTS, this goal has always been clear: To offer alternatives to patients who experience discomfort, swallowing difficulties or undesirable side effects caused by conventional dosage forms.
Drug Research > Drug Discovery & Development > White Papers
Mustang Bio announces expansion of CAR T pipeline into CD20-directed immunotherapies
Mustang Bio, a Fortress Biotech company, has announced the expansion of its pipeline of CAR T therapies into CD20-directed immunotherapies.
Drug Research > Drug Discovery & Development > News
BMS to use Halozyme’s Enhanze technology to develop immuno-oncology medicines
By PBR Staff Writer
Bristol-Myers Squibb (BMS) has partnered with Halozyme Therapeutics for the development of immuno-oncology medicines.
Drug Research > Drug Discovery & Development > News
Berkeley Lights, Bayer partner for cell line development and antibody discovery
Berkeley Lights (BLI), a company dedicated to bringing to market transformational platforms for bio-pharmaceutical processes, has announced a strategic project with Bayer, focused on the innovation and acceleration of cell line development, antibody discovery, and research.
Drug Research > Drug Discovery & Development > News
Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals
Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Summit Therapeutics awarded BARDA contract to develop Ridinilazole for CDI
Summit Therapeutics announces that the Biomedical Advanced Research and Development Authority (BARDA), an agency of the US government's Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, has awarded Summit a contract worth up to $62m.
Drug Research > Drug Discovery & Development > News
HitGen, Takeda enter DNA-encoded library based drug discovery research collaboration
HitGen announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company to discover novel small molecule leads for multiple targets in Takeda’s therapeutic areas of interest.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
Patient Focused Medicines Development (PFMD)
Patients Focused Medicine Development (PFMD) is an open, global and collaborative coalition of patient organisations and advocates, pharma and life sciences industry, HTA bodies, national advisory organisations and regulators. Their aim is to drive meaningful patient engagement by co-creating a standardised and globally adopted framework for patient engagement, so that patients' needs and priorities are at the core of medicines development and lifecycle. PFMD was established in 2015 and currently counts 24 members. Their 'Pledge to Patients' campaign encourages members of the medical community to commit to measurable actions to improve patient engagement.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Discovery & Development > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Discovery & Development > White Papers Vetter Commercial Manufacturing - Delivering results across the production chain By Vetter Pharma International
A unique blend of capabilities for aseptic fill and finish.... Drug Research > Drug Discovery & Development > White Papers Vetter Packaging Solutions - Delivering your product's potential By Vetter Pharma International
A unique blend of resources for filling and packaging.... Drug Research > Drug Discovery & Development > White Papers Vetter Development Service Chicago By Vetter Pharma International
Our premium manufacturing and clinical supply site near Chicago, Illinois, has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug compounds in any stage from Preclinical Testing to Phase II and beyond.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5645 results